Skip to main content
Veterinary Medicines

Duowin, Cutaneous Spray, Solution

Authorised
  • Pyriproxyfen
  • Permethrin (40:60)

Product identification

Medicine name:
Duowin, Cutaneous spray, Solution
Duowin, Cutaneous Spray, Solution
Active substance:
  • Pyriproxyfen
  • Permethrin (40:60)
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Pyriproxyfen
    0.02
    gram(s)
    /
    100.00
    millilitre(s)
  • Permethrin (40:60)
    1.88
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous spray, solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • 250 ml bottle made of high density polyethylene stopped with screw stoppers made of high density polyethylene.Mechanical spraying device made of polypropylene.Carton box containing one 250 ml polyethylene bottle fitted with one mechanical spraying device.
  • 500 ml bottle made of high density polyethylene stopped with screw stoppers made of high density polyethylene.Mechanical spraying device made of polypropylene.Carton box containing one 500 ml polyethylene bottle and one mechanical spraying device.
  • 250 ml bottle made of high density polyethylene stopped with screw stoppers made of high density polyethylene.Mechanical spraying device made of polypropylene.Carton box containing one 250 ml polyethylene bottle and one mechanical spraying device.
  • 500 ml bottle made of high density polyethylene stopped with screw stoppers made of high density polyethylene.Mechanical spraying device made of polypropylene.Carton box containing one 500 ml polyethylene bottle fitted with one mechanical spraying device.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 05653/4046
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0498/001
Concerned member states:
  • Austria
  • Luxembourg
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download